It does not come from large-scale human weight loss trials comparing sublingual drops to injectable semaglutide for appetite suppression and weight loss
Telos Rx publishes several trust signals in its own materials - a named operating entity, brand-stated LegitScript certification, HIPAA-related documentation, and named medical and pharmacy partners with real addresses and phone numbers
Enjoy ongoing care and support every step of the way
Pawar SS, Rasal PB, Kulkarni KH, Pawar SB
These findings carry clinical significance for obesity management
An October 2024 study in the Journal of the American Medical Association found that from 2010 to 2023, the proportion of type 1 diabetes patients being treated with GLP-1 receptor agonists grew from 0.3% to 6.6%indicating that even without the FDAs approval, physicians and prescribers appear to see the value of the drug class in this indication